However, a pooled analysis of nine randomized-controlled trials suggested that the remission-maintaining effect of mesalazine in patients after remission induction by surgical treatment is somewhat significant in suppressing relapse compared with placebo 6 .
← all excerpts
Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation.
1
—
—